TY - JOUR
T1 - Self-Monitoring and Self-Efficacy in Patients with Chronic Kidney Disease During Low-Sodium Diet Self-Management Interventions
T2 - Secondary Analysis of the ESMO and SUBLIME Trials
AU - Hoekstra, Tiny
AU - Dam, Manouk
AU - Klaassen, Gerald
AU - Bos, Willem Jan W.
AU - van der Boog, Paul J. M.
AU - Vogt, Liffert
AU - van Jaarsveld, Brigit
AU - van Dijk, Sandra
AU - Navis, Gerjan
AU - Meuleman, Yvette
AU - Kwakernaak, A.J.
N1 - Funding Information: The ESMO study was supported by grants from The Netherlands Organization for Health Research and Development - Medical Sciences (ZonMw: 300020016) and the Dutch Kidney Foundation (SB93). The SUBLIME study was funded by a grant from ZonMw (project number 837001005 of the ‘Doelmatigheidsonderzoek 2013–2015’ program) and the Dutch Kidney Foundation (PV48). They had no role in the study design (collecting, analysis, or interpretation of data), writing of the paper, and the decision to submit this paper. Publisher Copyright: © 2023, International Society of Behavioral Medicine.
PY - 2023
Y1 - 2023
N2 - Background: Patients with chronic kidney disease are often requested to engage in self-monitoring sodium (i.e. salt) intake, but it is currently unknown how self-monitoring would empower them. This study aims to assess: (1) how frequent self-monitoring tools are being used during low-sodium diet self-management interventions; (2) whether self-efficacy (i.e. trust in own capability to manage the chronic disease) is associated with self-monitoring frequency; and (3) whether higher self-monitoring frequency is associated with an improvement in self-efficacy over time. Method: Data from two multicenter randomized controlled trials (ESMO [n = 151] and SUBLIME [n = 99]) among adult Dutch patients with chronic kidney disease (eGFR ≥ 20–25 mL/min/1.73 m2) were used. In both studies, routine care was compared to a 3-month low-sodium diet self-management intervention with several self-monitoring tools (online food diary, home blood pressure monitor, and urinary sodium measurement device [only ESMO]). Data was collected on usage frequency of self-monitoring tools. Frequencies during the interventions were compared between low and high baseline self-efficacy groups using the Mann-Whitney U test and T-test and associated with changes in self-efficacy during the interventions using Spearman correlation coefficients. Results: Large variations in self-monitoring frequency were observed. In both interventions, usage of self-monitoring tools was highest during the first month with sharp drops thereafter. The online food diary was the most frequently used tool. In the ESMO intervention, low baseline self-efficacy was associated with a higher usage frequency of self-monitoring tools. This finding was not confirmed in the SUBLIME intervention. No significant associations were found between usage frequency of self-monitoring tools and changes in self-efficacy over time. Conclusion: Patients with low self-efficacy might benefit most from frequent usage of self-monitoring tools when sufficient guidance and support is provided.
AB - Background: Patients with chronic kidney disease are often requested to engage in self-monitoring sodium (i.e. salt) intake, but it is currently unknown how self-monitoring would empower them. This study aims to assess: (1) how frequent self-monitoring tools are being used during low-sodium diet self-management interventions; (2) whether self-efficacy (i.e. trust in own capability to manage the chronic disease) is associated with self-monitoring frequency; and (3) whether higher self-monitoring frequency is associated with an improvement in self-efficacy over time. Method: Data from two multicenter randomized controlled trials (ESMO [n = 151] and SUBLIME [n = 99]) among adult Dutch patients with chronic kidney disease (eGFR ≥ 20–25 mL/min/1.73 m2) were used. In both studies, routine care was compared to a 3-month low-sodium diet self-management intervention with several self-monitoring tools (online food diary, home blood pressure monitor, and urinary sodium measurement device [only ESMO]). Data was collected on usage frequency of self-monitoring tools. Frequencies during the interventions were compared between low and high baseline self-efficacy groups using the Mann-Whitney U test and T-test and associated with changes in self-efficacy during the interventions using Spearman correlation coefficients. Results: Large variations in self-monitoring frequency were observed. In both interventions, usage of self-monitoring tools was highest during the first month with sharp drops thereafter. The online food diary was the most frequently used tool. In the ESMO intervention, low baseline self-efficacy was associated with a higher usage frequency of self-monitoring tools. This finding was not confirmed in the SUBLIME intervention. No significant associations were found between usage frequency of self-monitoring tools and changes in self-efficacy over time. Conclusion: Patients with low self-efficacy might benefit most from frequent usage of self-monitoring tools when sufficient guidance and support is provided.
KW - Chronic kidney disease
KW - Randomized controlled trial
KW - Reducing dietary sodium intake
KW - Self-efficacy
KW - Self-managment and lifestyle support
KW - Self-monitoring tools
UR - http://www.scopus.com/inward/record.url?scp=85178948566&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s12529-023-10240-8
DO - https://doi.org/10.1007/s12529-023-10240-8
M3 - Article
C2 - 38066237
SN - 1070-5503
JO - International journal of behavioral medicine
JF - International journal of behavioral medicine
ER -